A demonstration for women's rights. Photo: Adam Berry/Getty Images

Of the 138 elected and appointed officials accused of sexual misconduct in the last election cycle, 104 will be out of office by January 2019, according to a new study by Georgetown Law Professor Jamillah Bowman Williams.

The big picture: The #MeToo movement swept across industries, and confronted politicians from state legislature to the top of federal government. Men accounted for 135 of the officials accused of harassment, assault, violence against women, or other sexual misconduct.

Details: Williams' research identifies the accused as 14 members of Congress, 84 state lawmakers, 13 other elected officials, 25 appointed officials and two former government officials currently running for office.

  • 18 of them were accused in the 10 months leading up to the #MeToo movement's beginning; the other 120 were accused after the news of Harvey Weinstein broke.
  • 77 of those accused were not in the running for re-election on Tuesday because they decided against it, resigned, or retired. Two committed suicide.
  • 9 officials were removed from office.
  • 15 lost their primaries.

Yes, but: 27 officials ran for office again in the midterms, and 23 were re-elected or elected to new positions. One race is headed for a recount. Williams writes in the report that voters "were focused on other political issues, such as health care, immigration, and the economy."

  • The accusations against those 27 range from negligence — including Jim Jordan (R-Ohio) — to a rape accusation against State Sen. Joe Fain (R-Washington). They also include harassment, domestic violence, and sexual assault.
  • Two of those 27 lost their races to women.

The bottom line: The #MeToo movement had a profound impact on the conversation around sexual harassment and assault, and in encouraging survivors to come forward and confront their abusers. But it's unlikely this is nearing its end.

Go deeper

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 10 p.m. EST: 32,135,220 — Total deaths: 981,660 — Total recoveries: 22,149,441Map.
  2. U.S.: Total confirmed cases as of 10 p.m EST: 6,975,980 — Total deaths: 202,738 — Total recoveries: 2,710,183 — Total tests: 98,481,026Map.
  3. Politics: House Democrats prepare new $2.4 trillion coronavirus relief package.
  4. Health: Cases are surging again in 22 states — New York will conduct its own review of coronavirus vaccine.
  5. Business: America is closing out its strongest quarter of economic growth.
  6. Technology: 2020 tech solutions may be sapping our resolve to beat the pandemic.
  7. Sports: Pac-12 will play this fall despite ongoing pandemic — Here's what college basketball will look like this season.
  8. Science: Global coronavirus vaccine initiative launches without U.S. or China — During COVID-19 shutdown, a common sparrow changed its song.
9 hours ago - Sports

Pac-12 will play football this fall, reversing course

A view of Levi's Stadium during the 2019 Pac-12 Championship football game. Photo: Alika Jenner/Getty Images

The Pac-12, which includes universities in Arizona, California, Colorado, Oregon, Utah and Washington state, will play football starting Nov. 6, reversing its earlier decision to postpone the season because of the coronavirus pandemic.

Why it matters: The conference's about-face follows a similar move by the Big Ten last week and comes as President Trump has publicly pressured sports to resume despite the ongoing pandemic. The Pac-12 will play a seven-game conference football season, according to ESPN.

Dave Lawler, author of World
10 hours ago - World

Global coronavirus vaccine initiative launches without U.S. or China

Data: Gavi, The Vaccine Alliance; Map: Naema Ahmed/Axios

A global initiative to ensure equitable distribution of coronavirus vaccines now includes most of the world — but not the U.S., China or Russia.

Why it matters: Assuming one or more vaccines ultimately gain approval, there will be a period of months or even years in which supply lags far behind global demand. The COVAX initiative is an attempt to ensure doses go where they're most needed, rather than simply to countries that can produce or buy them at scale.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!